l-Alanyl-l-glutamine Dipeptide-Supplemented Total Parenteral Nutrition
Glutamine is the most abundant free amino acid in the human body. It plays an important role in cellular metabolism and proliferation, as well as in immune regulation. It has been considered as “conditionally essential” in critical illnesses. The benefits behind using parenteral nutrition supplemented with glutamine on critically ill patients have received extensive support for many years from in vitro studies, animal models, and human studies. All of these have been further reinforced through systematic reviewing and meta-analysis. However, results from recent studies indicate that its prescription is controversial, it could be non-beneficial, and it may even be harmful if the patient type, timing, and dosage are not carefully selected.
KeywordsPlacebo Permeability Toxicity Ischemia Europe
List of Abbreviations
Intensive care unit
Multiple organ dysfunction syndrome
- Bonet Saris A, Márquez Vácaro JA, Serón Arbeloa C. Guidelines for specialized nutritional and metabolic support in the critically-ill patient. Update. Consensus of the Spanish Society of Intensive Care Medicine and Coronary Units-Spanish Society of Parenteral and Enteral Nutrition (SEMICYUC-SENPE): macro-and micronutrient requirements. Med Intensiva. 2011;35 Suppl 1:17–21.CrossRefPubMedGoogle Scholar
- Canadian Critical Care Nutrition Clinical Guidelines. Composition of parenteral nutrition: glutamine supplementation. www.criticalcarenutrition.com (2009). Accessed 16 July 2013.
- Déchelotte P, Hasselmann M, Cynober L, et al. L-alanyl-L-glutamine dipeptide-supplemented total parenteral nutrition reduces infectious complications and glucose intolerance in critically ill patients: the French controlled, randomized, double-blind, multicenter study. Crit Care Med. 2006;34:598–604.CrossRefPubMedGoogle Scholar
- Stein J, Boehles HJ, Blumenstein I, et al. Amino acids – guidelines on parenteral nutrition, chapter 4. Ger Med Sci. 2009;7:1–8.Google Scholar